Navigation Links
Use of Insecticides Linked to Lasting Neurological Problems for Farmers

New research shows that farmers who used agricultural insecticides experienced increased neurological symptoms, even when they were no longer using the products. Data from 18,782 North Carolina and Iowa farmers linked use of insecticides, including organophosphates and organochlorines, to reports of reoccurring headaches, fatigue, insomnia, dizziness, nausea, hand tremors, numbness and other neurological symptoms. Some of the insecticides addressed by the study are still on the market, but some, including DDT, have been banned or restricted.

These findings will be available online in April, and published in the June issue of Environmental Health Perspectives. The research is part of the ongoing Agricultural Health Study funded by the National Institute of Environmental Health Sciences and the National Cancer Institute, two of the National Institutes of Health, and the Environmental Protection Agency.

"This research is really important because it evaluated the health effects of agricultural chemicals as they were commonly used by farmers. It's different from previous studies that focused on pesticide poisoning or high dose exposures, for example when large amounts of a chemical were accidentally spilled on the skin," said Freya Kamel, Ph.D., a researcher for the National Institute of Environmental Health Sciences (NIEHS).

The NIEHS researchers examined questionnaires completed by farmers on lifetime exposure to herbicides, insecticides, fungicides, and fumigants, and their history of 23 neurological symptoms. Those who reported experiencing more than 10 symptoms during the year prior to completing a study questionnaire were classified as having high levels of symptoms.

Researchers found that nearly 3,000 participants had a high lifetime exposure to insecticides ?that is, they used insecticides more than 500 days in their lifetime. Nearly 800 of these farmers reported more than 10 neurological symptoms compared to those using insecticide
'"/>

Source:NIH


Page: 1 2

Related biology news :

1. Spider Venom Could Yield Eco-Friendly Insecticides
2. New SARS Protein Linked To Important Cell Doorway
3. Breast-Cancer Risk Linked to Exposure to Traffic Emissions at Menarche, First Birth
4. Nighttime Dying Linked To Sleep Apnea From Brain Cell Loss
5. Defective Gene Linked to Two Inherited Immune Deficiencies
6. HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs
Post Your Comments:
(Date:6/19/2013)... at the University of Pittsburgh has developed antibacterial ... that could be potential treatments for drug-resistant bacterial ... new agents are quite small, making them inexpensive ... in the June 2013 issue of the journal ... first of many probable applications will likely be ...
(Date:6/19/2013)... 19, 2013 MedNet Solutions , a ... management systems, is pleased to announce its participation in ... 23-27 in Boston .  This represents ... leader in cloud-based eClinical solutions, has exhibited at this ... iMedNet™ EDC , MedNet,s latest, easy-to-use ...
(Date:6/19/2013)... Insulin is the most potent physiological anabolic agent ... and synthesis of lipids, protein and carbohydrates, and ... system. It also plays a major role in ... glucose is metabolized and removed from the blood ... precise molecular mechanisms by which insulin regulates glucose ...
Breaking Biology News(10 mins):HIV-derived antibacterial shows promise against drug-resistant bacteria 2MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting 2Breakthrough research of essential molecule reveals important targets in diabetes and obesity 2
... is available in Spanish . , While the ... months, their properties have not been scientifically proven yet by ... berries, components are contained in the recommended fruit and vegetable ... placebo effect" on people consuming them. Also, the species Lycium ...
... 23andMe has launched a project funded by the National ... 23andMe,s highly-scalable platform for pharmacogenomics research. The company received ... Reinvestment Act of 2009 for "Web-based Phenotyping for Genome-Wide ... Genome Research Institute. "One of 23andMe,s ...
... area deep in the brain called the perirhinal cortex is ... Davis Center for Mind and Brain have found. The ... hippocampus, in "declarative" or conscious memories, but the new results ... Wei-chun Wang, a graduate student at UC Davis. The ...
Cached Biology News:Goji berries have the same nutrients as fruits and vegetables and a placebo effect 223andMe receives NIH funding to evaluate web-based research on the genetics of drug response 2Where unconscious memories form 2
(Date:6/19/2013)... June 20, 2013 New ... technology solutions for pharmaceutical and chemical sectors ... Manufacturing Pte. Ltd. and Siemens Pte. Ltd, have ... A*STAR R&D Consortium Programme - Innovative Processing of ... of Chemical and Engineering Sciences (ICES), the consortium ...
(Date:6/19/2013)... June 19, 2013 Bellevue city ... hall of technology solutions for people with disabilities ... Hyatt Regency Bellevue. , The exhibit hall, ... on Saturday and Sunday, will feature leading manufacturers ... wheelchairs, communication devices, eyegaze technologies, computer applications, and ...
(Date:6/19/2013)... 2013  U.S. Secretary of State John Kerry ... Syngenta  scientist Mary-Dell Chilton , Ph.D., was ... Prize. The prize is the foremost international award recognizing ... quality, quantity or availability of food in the world. ... recognized for "revolutionary biotechnology discoveries that unlocked the key ...
(Date:6/19/2013)... 19, 2013 Clinverse, Inc. ... for clinical trials, today announced it will be ... (booth #2000) in Boston, June 24-26, 2013. ... and only fully configurable, cloud-based clinical financial lifecycle ... module within Clinverse’s eClinical Commerce Network, automates site ...
Breaking Biology Technology:Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 2Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 3Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 4City of Bellevue, Wash., Welcomes Assistive Technology Exhibit Hall 2Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate 2Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013 2
... a liquid-crystal display (LCD) often indicate that a device,s ... Zhong Lin Wang at Georgia Tech, the blinking number ... five-year effort to power conventional electronic devices with nanoscale ... an array of tiny nanowires. In this case, ...
... Reportlinker.com announces that a new market research ... The Future of Molecular Diagnostics: ... medicine http://www.reportlinker.com/p0233955/The-Future-of-Molecular-Diagnostics-Innovative-technologies-driving-market-opportunities-in-personalized-medicine.html ... analysis of DNA and RNA at the ...
... 8, 2010 Reportlinker.com announces that a ... its catalogue: Biomarkers in ... activities of leading players ... and biotechnology sectors are currently facing increasing ...
Cached Biology Technology:Nanogenerators grow strong enough to power small conventional electronics 2Nanogenerators grow strong enough to power small conventional electronics 3Nanogenerators grow strong enough to power small conventional electronics 4The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine 2The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine 3The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine 4The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine 5The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine 6The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine 7The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine 8The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine 9Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players 2Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players 3Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players 4Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players 5Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players 6Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players 7Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players 8Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players 9
... The ISOQUANT(R) Isoaspartate Detection Kit is ... residues in proteins and peptides, which can ... asparagine or rearrangement of aspartic acid residues ... does not depend on the monitoring of ...
Request Info...
Rb anti-Occludin (C-term GST)...
Request Info...
Biology Products: